Review Article

Treatment of Hepatitis B in Decompensated Liver Cirrhosis

Table 3

Antiviral Agents with Activity against Wild Type and Lamivudine resistant HBV.

AgentDaily doseSide effectsComments

Adefovir10 mgDose-dependant nephrotoxicityDrug resistance after 12 months
Entecavir1 mgNo major side effects to dateDrug resistance eventually in lamivudine-resistant mutants
Tenofovir300 mgNeuropathy, nausea, CPK elevations, Fanconi syndromeNo drug resistance up to 4 years